Reply

Affiliations

Comment

Silvio Danese et al. Clin Gastroenterol Hepatol. 2020 Dec.

. 2020 Dec;18(13):3057-3058.

doi: 10.1016/j.cgh.2020.03.023.

No abstract available

Comment on

Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis.
Danese S, Neurath MF, Kopoń A, Zakko SF, Simmons TC, Fogel R, Siegel CA, Panaccione R, Zhan X, Usiskin K, Chitkara D. Danese S, et al. Clin Gastroenterol Hepatol. 2020 Oct;18(11):2526-2534.e9. doi: 10.1016/j.cgh.2019.12.032. Epub 2020 Jan 8. Clin Gastroenterol Hepatol. 2020. PMID: 31926340 Clinical Trial.
Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis.
Nittala R, Singh A. Nittala R, et al. Clin Gastroenterol Hepatol. 2020 Dec;18(13):3057. doi: 10.1016/j.cgh.2020.02.038. Epub 2020 Feb 25. Clin Gastroenterol Hepatol. 2020. PMID: 32109638 No abstract available.